BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bao X, Zeng J, Huang H, Ma C, Wang L, Wang F, Liao X, Song X. Cancer-targeted PEDF-DNA therapy for metastatic colorectal cancer. Int J Pharm 2020;576:118999. [PMID: 31893541 DOI: 10.1016/j.ijpharm.2019.118999] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Younis NK, Roumieh R, Bassil EP, Ghoubaira JA, Kobeissy F, Eid AH. Nanoparticles: attractive tools to treat colorectal cancer. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.08.006] [Reference Citation Analysis]
2 Luiz MT, Dutra JAP, Tofani LB, de Araújo JTC, Di Filippo LD, Marchetti JM, Chorilli M. Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy. Pharmaceutics 2022;14:821. [DOI: 10.3390/pharmaceutics14040821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sheikh A, Md S, Kesharwani P. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer. Biomed Pharmacother 2021;146:112530. [PMID: 34915416 DOI: 10.1016/j.biopha.2021.112530] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
4 Sheikh A, Md S, Kesharwani P. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. J Control Release 2021;340:221-42. [PMID: 34757195 DOI: 10.1016/j.jconrel.2021.10.028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abooshahab R, Al-Salami H, Dass CR. The increasing role of pigment epithelium-derived factor in metastasis: from biological importance to a promising target. Biochem Pharmacol 2021;193:114787. [PMID: 34571004 DOI: 10.1016/j.bcp.2021.114787] [Reference Citation Analysis]
6 Si Y, Zhang Y, Ngo HG, Guan JS, Chen K, Wang Q, Singh AP, Xu Y, Zhou L, Yang ES, Liu XM. Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer. Cancers (Basel) 2021;13:3749. [PMID: 34359650 DOI: 10.3390/cancers13153749] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
7 Sang R, Stratton B, Engel A, Deng W. Liposome technologies towards colorectal cancer therapeutics. Acta Biomater 2021;127:24-40. [PMID: 33812076 DOI: 10.1016/j.actbio.2021.03.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Şen Ö, Emanet M, Ciofani G. Nanotechnology-Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis. Adv Healthc Mater 2021;10:e2002163. [PMID: 33763992 DOI: 10.1002/adhm.202002163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yahya EB, Alqadhi AM. Recent trends in cancer therapy: A review on the current state of gene delivery. Life Sci 2021;269:119087. [PMID: 33476633 DOI: 10.1016/j.lfs.2021.119087] [Cited by in Crossref: 7] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
10 Xiao S, Chen L. The emerging landscape of nanotheranostic-based diagnosis and therapy for osteoarthritis. J Control Release 2020;328:817-33. [PMID: 33176171 DOI: 10.1016/j.jconrel.2020.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kang S, Lee S, Park S. iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery. Polymers (Basel) 2020;12:E1906. [PMID: 32847045 DOI: 10.3390/polym12091906] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
12 Huang H, Yang X, Li H, Lu H, Oswald J, Liu Y, Zeng J, Jin C, Peng X, Liu J, Song X. iRGD decorated liposomes: A novel actively penetrating topical ocular drug delivery strategy. Nano Res 2020;13:3105-9. [DOI: 10.1007/s12274-020-2980-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Shi X, Ma R, Lu Y, Cheng Y, Fan X, Zou J, Zheng H, Li F, Piao J. iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas. Biochemical and Biophysical Research Communications 2020;527:117-23. [DOI: 10.1016/j.bbrc.2020.04.064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]